Analyze Diet
Journal of equine veterinary science2025; 149; 105570; doi: 10.1016/j.jevs.2025.105570

Metformin and rosiglitazone affect motility, lipid peroxidation and mitochondrial activity of thawed equine spermatozoa.

Abstract: Maintaining sperm energy homeostasis in vitro is very important to improve the efficacy of stallion sperm preservation. Equine spermatozoa preferentially utilize oxidative phosphorylation over glycolysis to generate ATP. Metformin and rosiglitazone are antidiabetic compounds that enhances metabolic flexibility and glucose utilization. The aim of this study was to evaluate metformin and rosiglitazone supplementation of the freezing medium on quality and oxidative status of thawed stallion semen. A total of 15 ejaculates from five horses were collected and supplemented before freezing with metformin at 20 (M20), 50 (M50) and 100 mM (M100) and with rosiglitazone at 10 (R10), 50 (R50) and 100 µM (R100). A control group without supplementation was added. Semen cryopreservation was performed using a programable freezing protocol. Post-thaw, motility and kinetics, vitality (SV), morphology, plasma membrane integrity (PMI), mitochondria membrane potential (ΔΨM), reactive oxygen species (ROS) and lipid peroxidation (LP) of sperm were evaluated. Mixed models were adjusted and means were compared using Tukey tests. Total motility of post-thawed semen increased with M20; M100 reduced motility and most of the sperm kinetic parameters, as well as SV and PMI (p < 0.05). A reduction in LP was observed with M20 and R100; also, M100 produced a higher population of spermatozoa with low and high ΔΨM (p < 0.05). No treatment, except R50, generated an overproduction of ROS. In conclusion, a dose of 20 mM metformin in the freezing extender for stallion semen could improve total motility and reduce lipid peroxidation of thawed spermatozoa.
Publication Date: 2025-04-11 PubMed ID: 40222464DOI: 10.1016/j.jevs.2025.105570Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the effect of metformin and rosiglitazone, two antidiabetic drugs, on the vitality and oxidative status of frozen-thawed stallion semen. It shows that the right dosage of metformin can improve sperm motility and reduce lipid peroxidation, factors important for successful horse breeding.

Objective of Research and Methodology

  • The study aimed to evaluate the impact of metformin and rosiglitazone (two antidiabetic compounds) supplementation on the quality and oxidative status of thawed stallion semen.
  • The researchers collected a total of 15 ejaculates from five horses and supplemented these with varying doses of metformin and rosiglitazone prior to freezing. A control group was also set up without any supplementation.
  • The sperm was then cryopreserved using a programmable freezing protocol. Post-freezing, various parameters of the sperm, including motility, vitality, plasma membrane integrity and mitochondrial activity, reactive oxygen species and lipid peroxidation, were evaluated.

Key Findings

  • The study found that metformin at a dose of 20mM (M20) increased the total motility of thawed semen. However, at higher 100mM concentration (M100), motility decreased along with most of the sperm kinetic parameters.
  • Both metformin at 20mM and rosiglitazone at 100µM (R100) resulted in a reduction in lipid peroxidation. Metformin at 100mM resulted in a higher population of spermatozoa with both low and high mitochondrial membrane potential (ΔΨM).
  • None of the treatments, except rosiglitazone at 50 µM (R50), resulted in the overproduction of reactive oxygen species (ROS).

Conclusion

  • In sum, the researchers concluded that supplementation with a dose of 20 mM metformin in the freezing extender for stallion semen can improve overall motility and reduce lipid peroxidation of thawed spermatozoa.
  • This finding could have important implications for horse breeding, as maintaining sperm energy homeostasis is crucial to improving the efficiency of stallion sperm preservation.

Cite This Article

APA
Usuga A, Vergara AK, Tobón MC, Vargas S, Rojano B, Restrepo G. (2025). Metformin and rosiglitazone affect motility, lipid peroxidation and mitochondrial activity of thawed equine spermatozoa. J Equine Vet Sci, 149, 105570. https://doi.org/10.1016/j.jevs.2025.105570

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 149
Pages: 105570
PII: S0737-0806(25)00228-X

Researcher Affiliations

Usuga, Alexandra
  • Biogénesis Research Group, Faculty of Agricultural Sciences, Universidad de Antioquia, Medellín, Colombia; Faculty of Veterinary Medicine and Animal Science, Universidad CES, Medellín, Antioquia, Colombia. Electronic address: alexandra.usuga@udea.edu.co.
Vergara, Ana Karina
  • Faculty of Veterinary Medicine and Animal Science, Universidad CES, Medellín, Antioquia, Colombia.
Tobón, María Camila
  • Faculty of Veterinary Medicine and Animal Science, Universidad CES, Medellín, Antioquia, Colombia.
Vargas, Santiago
  • Faculty of Veterinary Medicine and Animal Science, Universidad CES, Medellín, Antioquia, Colombia.
Rojano, Benjamín
  • Faculty of Science, Universidad Nacional de Colombia sede Medellín, Antioquia, Colombia.
Restrepo, Giovanni
  • Faculty of Agricultural Sciences, Universidad Nacional de Colombia sede Medellín, Antioquia, Colombia.

MeSH Terms

  • Animals
  • Horses / physiology
  • Male
  • Sperm Motility / drug effects
  • Spermatozoa / drug effects
  • Spermatozoa / physiology
  • Semen Preservation / veterinary
  • Metformin / pharmacology
  • Lipid Peroxidation / drug effects
  • Cryopreservation / veterinary
  • Rosiglitazone / pharmacology
  • Mitochondria / drug effects
  • Mitochondria / physiology
  • Hypoglycemic Agents / pharmacology

Conflict of Interest Statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Citations

This article has been cited 0 times.